The Stocks To Buy Now Tip Of The Week

eXp World Holdings Inc. (EXPI)

eXp World Holdings Inc. is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents.


If there is a stock you would like our team to review, let us know!
Submit Suggestion

Specializing in Micro-Cap and Small-Cap Stocks

“StocksToBuyNow” Newsletter

Every day there are thousands of stocks you can buy, but only a few will turn a big profit in a short amount of time. Our site is dedicated to finding stocks with action. No investor wants to be stuck with an underperforming, stagnating investment. Whether you follow us on social media, subscribe to our newsletter, or simply visit us once in a while to see the latest tip of the week, you will always find hot stocks you can put on your radar screen.

Get it Today! Simply provide your name and email below.

Stock Market Guide

How to Tell Which Stocks to Buy Now

We have put together a full guide to help micro-cap and small-cap
investors evaluate potential investments.

Claim Your Stock Market Guide

Get Instant Stock Alerts via Text

Ever hear a stock tip too late? Get immediate notification by singing up for GotStockTips?™

Text stocks to 77948
or complete the form.

Although this service is free, message and data rates from carrier may apply. FAQs.

GotStockTips is an affiliate network partner of DTN.

Cell Number (US Only)
You will receive alerts from GotStockTips.
Get 6 messages per month.
Text HELP for help. Text STOP to cancel.
Msg&Data rates may apply.
Collected data is private and will not be sold
or shared with any other third party.

About Our Brand

We're constantly scanning the micro-cap and small-cap market for volume breakouts, hot press releases, and large percentage gainers getting the attention of the market.

Learn More >

Latest From Twitter

Follow us: @Buy_Stocks_Now

From Our Blog

ContraVir Pharmaceuticals, Inc. (CTRV) Set to Shake Up HBV Therapy Market with Combination Therapy Based on CMX157 & CRV431

October 20, 2016

A constant theme that comes up in and often dominates the leading edge of the biopharma sector is the building of better mousetraps. This is certainly the case for New Jersey-based biopharma developer ContraVir Pharmaceuticals (NASDAQ: CTRV), whose phase 2a clinical antiviral candidate CMX157 ( is knocking loudly on the door of Gilead Sciences’ (NASDAQ: […]

Rotate your device 90° to view site.